JAMP Pentoxifylline SR 400mg: Affected lot may contain Sitagliptin 100mg tablets.

Product safety

Date

2025-05-05

Country

Canada

Product

JAMP Pentoxifylline SR

Classification

Type III

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2025-05-07
2. CA
   Drugs & medicalType II

   Beckman Coulter Au480 and Au680 Immunochemistry Systems

   Performance

   Health CanadaOfficial notice →
3. CA
   Drugs & medicalType II

   Beckman Coulter Au Immunochemistry System - Apolipoprotein B

   Labelling and packaging

   Health CanadaOfficial notice →
4. CA
   Drugs & medicalType II

   Dexcom G7 iOS Continuous Glucose Monitoring (CGM) App

   Performance

   Health CanadaOfficial notice →
5. 2025-05-05
6. CA
   Drugs & medicalType I

   JAMP-Pregabalin: One lot recalled as some bottles may contain 150 mg capsules

   Product safety

   Health CanadaOfficial notice →
7. 2025-05-03
8. CA
   Drugs & medical

   JAMP-Pregabalin 50 mg: One lot recalled as some bottles may contain 150 mg capsules

   Product safety

   Health CanadaOfficial notice →
9. 2025-05-02
10. CA
    Drugs & medicalType III

    Sylvant 400mg: Affected lot is labelled with the incorrect expiry date found on the vial and carton.

    Product quality

    Health CanadaOfficial notice →